Sofinnova Venture Partners IX, L.P.

Sofinnova Venture Partners IX, L.P. has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Iterum Therapeutics plc, NextCure, Inc. and Entasis Therapeutics Holdings Inc. Between 30 May 2018 and 2 June 2020, the trades on record add up to 17 filings.

On the open market, the record shows 5 purchases worth €28.4M and 2 sales worth €727k. On balance, insiders were net buyers of €27.7M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2020, the count stands at no purchases and 2 sales.

The median purchase comes to €5.3M. Of 4 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

Most recently, on 3 June 2020, the filings show an open-market sale worth €152k in Iterum Therapeutics plc. The last insider purchase was made public on 19 November 2019, 2,530 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.